乙胺丁醇在肺结核复治中的应用 - Suppr

Suppr

超能文献

Ethambutol in the retreatment of pulmonary tuberculosis.

作者信息

Bobrowitz I D

出版信息

Ann N Y Acad Sci. 1966 Apr 20;135(2):796-822. doi: 10.1111/j.1749-6632.1966.tb45523.x.

DOI:10.1111/j.1749-6632.1966.tb45523.x

PMID:5220240

Abstract

摘要

相似文献

Ethambutol in the retreatment of pulmonary tuberculosis.

Ann N Y Acad Sci. 1966 Apr 20;135(2):796-822. doi: 10.1111/j.1749-6632.1966.tb45523.x.

Metabolic and special studies of ethambutol in normal volunteers and tuberculous patients.

Ann N Y Acad Sci. 1966 Apr 20;135(2):775-95. doi: 10.1111/j.1749-6632.1966.tb45522.x.

Clinical evaluation of ethambutol in pulmonary tuberculosis.

Ann N Y Acad Sci. 1966 Apr 20;135(2):849-81. doi: 10.1111/j.1749-6632.1966.tb45528.x.

Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.

Ann N Y Acad Sci. 1966 Apr 20;135(2):835-45. doi: 10.1111/j.1749-6632.1966.tb45526.x.

Ocular toxicity from ethambutol.

N Z Med J. 1999 Feb 26;112(1082):57-8.

Retreatment of pulmonary tuberculosis with ethambutol.

Ann N Y Acad Sci. 1966 Apr 20;135(2):882-9. doi: 10.1111/j.1749-6632.1966.tb45529.x.

Visual function in patients on ethambutol therapy for tuberculosis.

J Ocul Pharmacol Ther. 2012 Apr;28(2):174-8. doi: 10.1089/jop.2011.0095. Epub 2011 Dec 2.

The ocular toxicity of ethambutol and its relation to dose.

Ann N Y Acad Sci. 1966 Apr 20;135(2):904-9. doi: 10.1111/j.1749-6632.1966.tb45532.x.

Multi-drug therapy including ethambutol in retreatment of pulmonary tuberculosis.

Ann N Y Acad Sci. 1966 Apr 20;135(2):823-30. doi: 10.1111/j.1749-6632.1966.tb45524.x.

Incidence of toxic optic neuropathy with low-dose ethambutol.

Int J Tuberc Lung Dis. 2016 Feb;20(2):261-4. doi: 10.5588/ijtld.15.0275.

引用本文的文献

Prevalence and Incidence of Ethambutol-Induced Optic Neuropathy and Its Risk Factors in Korea: A Nationwide Population-Based Study.

J Korean Med Sci. 2025 May 26;40(20):e65. doi: 10.3346/jkms.2025.40.e65.

Visual Recovery Time in Patients with Ethambutol-induced Toxic Optic Neuropathy.

Korean J Ophthalmol. 2024 Apr;38(2):91-97. doi: 10.3341/kjo.2023.0095. Epub 2024 Feb 14.

Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.

Intern Med. 2021 Jun 1;60(11):1785-1788. doi: 10.2169/internalmedicine.6178-20. Epub 2020 Dec 29.

A prospective study of ocular toxicity in patients receiving ethambutol as a part of directly observed treatment strategy therapy.

Lung India. 2015 Jan-Feb;32(1):16-9. doi: 10.4103/0970-2113.148428.

Clinical pharmacokinetics of the antituberculosis drugs.

Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Ethambutol in the retreatment of pulmonary tuberculosis.

Ann N Y Acad Sci. 1966 Apr 20;135(2):796-822. doi: 10.1111/j.1749-6632.1966.tb45523.x.

Metabolic and special studies of ethambutol in normal volunteers and tuberculous patients.

Ann N Y Acad Sci. 1966 Apr 20;135(2):775-95. doi: 10.1111/j.1749-6632.1966.tb45522.x.

Clinical evaluation of ethambutol in pulmonary tuberculosis.

Ann N Y Acad Sci. 1966 Apr 20;135(2):849-81. doi: 10.1111/j.1749-6632.1966.tb45528.x.

Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation.

Ann N Y Acad Sci. 1966 Apr 20;135(2):835-45. doi: 10.1111/j.1749-6632.1966.tb45526.x.

Ocular toxicity from ethambutol.

N Z Med J. 1999 Feb 26;112(1082):57-8.

Retreatment of pulmonary tuberculosis with ethambutol.

Ann N Y Acad Sci. 1966 Apr 20;135(2):882-9. doi: 10.1111/j.1749-6632.1966.tb45529.x.

Visual function in patients on ethambutol therapy for tuberculosis.

J Ocul Pharmacol Ther. 2012 Apr;28(2):174-8. doi: 10.1089/jop.2011.0095. Epub 2011 Dec 2.

The ocular toxicity of ethambutol and its relation to dose.

Ann N Y Acad Sci. 1966 Apr 20;135(2):904-9. doi: 10.1111/j.1749-6632.1966.tb45532.x.

Multi-drug therapy including ethambutol in retreatment of pulmonary tuberculosis.

Ann N Y Acad Sci. 1966 Apr 20;135(2):823-30. doi: 10.1111/j.1749-6632.1966.tb45524.x.

Incidence of toxic optic neuropathy with low-dose ethambutol.

Int J Tuberc Lung Dis. 2016 Feb;20(2):261-4. doi: 10.5588/ijtld.15.0275.

引用本文的文献

Prevalence and Incidence of Ethambutol-Induced Optic Neuropathy and Its Risk Factors in Korea: A Nationwide Population-Based Study.

J Korean Med Sci. 2025 May 26;40(20):e65. doi: 10.3346/jkms.2025.40.e65.

Visual Recovery Time in Patients with Ethambutol-induced Toxic Optic Neuropathy.

Korean J Ophthalmol. 2024 Apr;38(2):91-97. doi: 10.3341/kjo.2023.0095. Epub 2024 Feb 14.

Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.

Intern Med. 2021 Jun 1;60(11):1785-1788. doi: 10.2169/internalmedicine.6178-20. Epub 2020 Dec 29.

A prospective study of ocular toxicity in patients receiving ethambutol as a part of directly observed treatment strategy therapy.

Lung India. 2015 Jan-Feb;32(1):16-9. doi: 10.4103/0970-2113.148428.

Clinical pharmacokinetics of the antituberculosis drugs.

Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.